Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial

The pathophysiology of heart failure with preserved ejection fraction (HFpEF) is poorly understood and therapeutic strategies are lacking. This study aimed to identify plasma proteins with pathophysiological relevance in HFpEF and with respect to spironolactone-induced effects. We assessed 92 biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnelle, Moritz, Leha, Andreas, Eidizadeh, Abass, Fuhlrott, Katharina, Trippel, Tobias D., Hashemi, Djawid, Toischer, Karl, Wachter, Rolf, Herrmann-Lingen, Christoph, Hasenfuß, Gerd, Pieske, Burkert, Binder, Lutz, Edelmann, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535031/
https://www.ncbi.nlm.nih.gov/pubmed/34685778
http://dx.doi.org/10.3390/cells10102796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535031/
https://www.ncbi.nlm.nih.gov/pubmed/34685778
http://dx.doi.org/10.3390/cells10102796

Ejemplares similares